Intradermal immune response after infection with Vaccinia virus

Journal of General Virology

Volumn 87, Issue 5, 2006, Pages 1157-1161

  Jacobs, Nathalie ^a   Chen, Ron A J ^a   Gubser, Caroline ^a   Najarro, Pilar ^a   Smith, Geoffrey L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL MARKER; T LYMPHOCYTE RECEPTOR; VACCINIA VACCINE; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL KINETICS; CONTROLLED STUDY; DATA ANALYSIS; DNA MODIFICATION; GRANULOCYTE; IMMUNE RESPONSE; LEUKOCYTE; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN DEFECT; T LYMPHOCYTE SUBPOPULATION; VIRAL SKIN DISEASE;

ADMINISTRATION, CUTANEOUS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; GENE REARRANGEMENT, DELTA-CHAIN T-CELL ANTIGEN RECEPTOR; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; GRANULOCYTES; KILLER CELLS, NATURAL; LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED BALB C; SKIN; SMALLPOX VACCINE; T-LYMPHOCYTES; TIME FACTORS; VACCINATION; VACCINIA; VACCINIA VIRUS;

MURINAE; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 33646136469     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81556-0     Document Type: Article

References (36)

1. Amara, R. R., Nigam, P., Sharma, S., Liu, J. & Bostik, V. (2004). Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells. J Virol 78, 3811-3816.
2. + dendritic epidermal cells. Cell 55, 837-847.
3. Belkaid, Y., Jouin, H. & Milon, G. (1996). A method to recover, enumerate and identify lymphomyeloid cells present in an inflammatory dermal site: a study in laboratory mice. J Immunol Methods 199, 5-25.
4. Belkaid, Y., Kamhawi, S., Modi, G., Valenzuela, J., Noben-Trauth, N., Rowton, E., Ribeiro, J. & Sacks, D. L. (1998). Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med 188, 1941-1953.
5. Belshe, R. B., Newman, F. K., Frey, S. E., Couch, R. B., Treanor, J. J., Tacket, C. O. & Yan, L. (2004). Dose-dependent neutralizing-antibody responses to vaccinia. J Infect Dis 189, 493-497.
6. Belyakov, I. M., Earl, P., Dzutsev, A. & 8 other authors (2003). Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci U S A 100, 9458-9463.
7. Bukowski, J. F., Woda, B. A., Habu, S., Okumura, K. & Welsh, R. M. (1983). Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 131, 1531-1538.
8. Combadiere, B., Boissonnas, A., Carcelain, G., Lefranc, E., Samri, A., Bricaire, F., Debre, P. & Autran, B. (2004). Distinct time effects of vaccination on long-term proliferative and IFN-γ-producing T cell memory to smallpox in humans. J Exp Med 199, 1585-1593.
9. Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L. & Ahmed, R. (2003). Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 171, 4969-4973.
10. Davies, D. H., McCausland, M. M., Valdez, C. & 7 other authors (2005). Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J Virol 79, 11724-11733.
11. Dupasquier, M., Stoitzner, P., Oudenaren, A., Romani, N. & Leenen, P. J. M. (2004). Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J Invest Dermatol 123, 876-879.
12. Earl, P. L., Americo, J. L., Wyatt, L. S. & 15 other authors (2004). Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 428, 182-185.
13. Fogg, C., Lustig, S., Whitbeck, J. C., Eisenberg, R. J., Cohen, G. H. & Moss, B. (2004). Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions. J Virol 78, 10230-10237.
14. Frey, S. E., Newman, F. K., Yan, L., Lottenbach, K. R. & Belshe, R. B. (2003). Response to smallpox vaccine in persons immunized in the distant past. JAMA 289, 3295-3299.
15. Greenberg, R. N., Kennedy, J. S., Clanton, D. J., Plummer, E. A., Hague, L., Cruz, J., Ennis, F. A., Blackwelder, W. C. & Hopkins, R. J. (2005). Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial. Lancet 365, 398-409.
16. Hammarlund, E., Lewis, M. W., Hansen, S. G., Strelow, L. I., Nelson, J. A., Sexton, G. J., Hanifin, J. M. & Slifka, M. K. (2003). Duration of antiviral immunity after smallpox vaccination. Nat Med 9, 1131-1137.
17. Hawlisch, H., Belkaid, Y., Baelder, R., Hildeman, D., Gerard, C. & Köhl, J. (2005). C5a negatively regulates Toll-like receptor 4-induced immune responses. Immunity 22, 415-426.
18. Kambayashi, T., Assarsson, E., Chambers, B. J. & Ljunggren, H. G. (2001). Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection. Eur J Immunol 31, 1523-1530.
19. Kennedy, M. K., Glaccum, M., Brown, S. N. & 13 other authors (2000). Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191, 771-780.
20. Moss, B. & Shisler, J. L. (2001). Immunology 101 at poxvirus U: immune evasion genes. Semin Immunol 13, 59-66.
21. Natuk, R. J. & Welsh, R. M. (1987). Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication. J Immunol 138, 877-883.
22. + γδ T cells play protective roles at an early phase of murine cytomegalovirus infection through production of interferon-γ. Immunology 99, 187-194.
23. Prlic, M., Gibbs, J. & Jameson, S. C. (2005). Characteristics of NK cell migration early after vaccinia infection. J Immunol 175, 2152-2157.
24. Pütz, M. M., Alberini, I., Midgley, C. M., Manini, I., Montomoli, E. & Smith, G. L. (2005). Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy. J Gen Virol 86, 2955-2960.
25. Reading, P. C. & Smith, G. L (2003). A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J Gen Virol 84, 1973-1983.
26. Rock, M. T., Yoder, S. M., Wright, P. F., Talbot, T. R., Edwards, K. M. & Crowe, J. E., Jr (2005). Differential regulation of granzyme and perforin in effector and memory T cells following smallpox immunization. J Immunol 174, 3757-3764.
27. Selin, L. K., Santolucito, P. A., Pinto, A. K., Szomolanyi-Tsuda, E. & Welsh, R. M. (2001). Innate immunity to viruses: control of vaccinia virus infection by γδ T cells. J Immunol 166, 6784-6794.
28. + T cells. J Immunol 164, 2009-2015.
29. Smith, G. L., Mackett, M. & Moss, B. (1983). Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 302, 490-495.
30. Smith, G. L., Symons, J. A., Khanna, A., Vanderplasschen, A. & Alcami, A. (1997). Vaccinia virus immune evasion. Immunol Rev 159, 137-154.
31. Symons, J. A., Adams, E., Tscharke, D. C., Reading, P. C., Waldmann, H. & Smith, G. L. (2002). The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. J Gen Virol 83, 2833-2844.
32. Tscharke, D. C. & Smith, G. L. (1999). A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. J Gen Virol 80, 2751-2755.
33. Tscharke, D. C., Reading, P. C. & Smith, G. L. (2002). Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol 83, 1977-1986.
34. Wang, T., Scully, E., Yin, Z. & 7 other authors (2003). IFN-γ-producing γδ T cells help control murine West Nile virus infection. J Immunol 171, 2524-2531.
35. Wilcock, D., Duncan, S. A., Traktman, P., Zhang, W.-H. & Smith, G. L. (1999). The vaccinia virus A40R gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface. J Gen Virol 80, 2137-2148.
36. Xu, R., Johnson, A. J., Liggitt, D. & Bevan, M. J. (2004). Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol 172, 6265-6271.